| Dec 17, 2025 |
Dec 19, 2025 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Sell |
97.5
|
+30,536
|
36.68%
|
✗
|
$483.9K |
| Nov 28, 2025 |
Dec 2, 2025 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Sell |
40.0
|
-48,375
|
-36.75%
|
✗
|
$755.6K |
| Sep 25, 2025 |
Sep 26, 2025 |
Phathom Pharmaceuticals, Inc.
|
CEO |
Sell |
40.0
|
-48,375
|
-53.75%
|
✗
|
$564.1K |
| Dec 11, 2019 |
Dec 16, 2019 |
VYNE Therapeutics Inc.
|
CEO |
Sell |
20.0
|
-85,210
|
-14.67%
|
✗
|
$385.1K |
| Dec 11, 2019 |
Dec 13, 2019 |
VYNE Therapeutics Inc.
|
CEO |
Sell |
20.0
|
-85,210
|
-14.67%
|
✗
|
$385.1K |
| Nov 21, 2016 |
Nov 22, 2016 |
KalVista Pharmaceuticals, Inc.
|
Director |
Sell |
27.5
|
-1,125
|
-100.00%
|
✗
|
$9.7K |